Brookfield Asset Management - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 194 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
Brookfield Asset Management ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$1,458,127
+17.8%
150,633
+50.6%
0.01%
+20.0%
Q1 2022$1,238,000
-82.5%
100,000
-67.7%
0.01%
-81.5%
Q4 2021$7,090,000
+560.1%
310,000
+538.9%
0.03%
+575.0%
Q3 2021$1,074,000
+75.2%
48,518
+2.6%
0.00%
+33.3%
Q2 2021$613,00047,3070.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders